Bephenium hydroxynaphthoate

This classification denotes an antihelminthic agent with the molecular formula C17H22NO.C11H7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47RU9546DX, chemically known as benzenemethanaminium, n,n-dimethyl-n-(2-phenoxyethyl)-, salt with 3-hydroxy-2-naphthalenecarboxylic acid (1:1) but more generally known as bephenium hydroxynaphthoate, which bears US NIH Compound Identifier 19666. European Medicines Agency schedules Bephenium hydroxynaphthoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05776MIG. The term BEPHENIUM HYDROXYNAPHTHOATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). Most nations, for tariff and trade purposes, schedule bephenium hydroxynaphthoate under HS 29239000 and SITC 51481. As of Q4 2014, BEPHENIUM HYDROXYNAPHTHOATE remains US FDA's Preferred Term for this commodity. Bephenium hydroxynaphthoate bears US NLM identifiers UMLS ID C0053335 and NCI Concept Code C75210. SMILES: C[N+](C)(CCOC1CCCCC1)CC2CCCCC2.C1CCC2CC(C(CC2C1)C(=O)[O-])O.